骨髓纤维化-话题@MedSci

#骨髓纤维化#

5篇内容 | 2057人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2247301, encodeId=bc0a224e301ed, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a>, objectTitle=原发性骨髓纤维化前期（prePMF）和PMF纤维化期、WHO骨髓纤维化分级, objectType=article, longId=858928, objectId=607b8589283d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250109/1736421969271_8538692.png, objectUrl=/article/show_article.do?id=607b8589283d, replyNumber=0, likeNumber=9, createdTime=2025-01-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=607b8589283d, moduleTitle=原发性骨髓纤维化前期（prePMF）和PMF纤维化期、WHO骨髓纤维化分级, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=607b8589283d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2239288, encodeId=76f1223928844, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=11fe2435ff' target=_blank style='color:#2F92EE;'>#AML#</a>, objectTitle=【JHO】MD安德森癌症中心大样本研究，AML伴骨髓纤维化的特征和预后, objectType=article, longId=852207, objectId=762285220e0d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20241120/1732067479023_8538692.jpg, objectUrl=/article/show_article.do?id=762285220e0d, replyNumber=0, likeNumber=35, createdTime=2024-11-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陕西省, moduleDTOList=[ModuleDTO(moduleId=762285220e0d, moduleTitle=【JHO】MD安德森癌症中心大样本研究，AML伴骨髓纤维化的特征和预后, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=762285220e0d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2230701, encodeId=af8f2230e0132, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=cd401200939c' target=_blank style='color:#2F92EE;'>#半凝集素-1轴#</a>, objectTitle=Science子刊：复旦大学王冠琳等绘制了骨髓纤维化骨髓中骨髓细胞类型之间的串扰图谱！, objectType=article, longId=846251, objectId=6bae8462517e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401012/1728725873419_8538692.jpg, objectUrl=/article/show_article.do?id=6bae8462517e, replyNumber=0, likeNumber=98, createdTime=2024-10-13, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6bae8462517e, moduleTitle=Science子刊：复旦大学王冠琳等绘制了骨髓纤维化骨髓中骨髓细胞类型之间的串扰图谱！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6bae8462517e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223440, encodeId=0dee2223440cf, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=eb2152482d7' target=_blank style='color:#2F92EE;'>#急性髓系白血病#</a>, objectTitle=【BMT】姜尔烈/翟卫华教授团队发现骨髓纤维化影响AML异基因移植结局, objectType=article, longId=841154, objectId=63a88411548e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721281386020_92910.jpg, objectUrl=/article/show_article.do?id=63a88411548e, replyNumber=0, likeNumber=93, createdTime=2024-09-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=63a88411548e, moduleTitle=【BMT】姜尔烈/翟卫华教授团队发现骨髓纤维化影响AML异基因移植结局, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=63a88411548e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2219509, encodeId=46bc221950915, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=b2d849e64c4' target=_blank style='color:#2F92EE;'>#异基因移植#</a>, objectTitle=【TCT】≥70岁骨髓纤维化患者异基因移植是可行的, objectType=article, longId=838436, objectId=9fc9838436f9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240730/1722330274156_8538692.jpg, objectUrl=/article/show_article.do?id=9fc9838436f9, replyNumber=0, likeNumber=126, createdTime=2024-08-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9fc9838436f9, moduleTitle=【TCT】≥70岁骨髓纤维化患者异基因移植是可行的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9fc9838436f9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2216250, encodeId=5150221625013, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=7cca11468472' target=_blank style='color:#2F92EE;'>#EHA 2024#</a> <a href='/topic/show?id=067a11695e4c' target=_blank style='color:#2F92EE;'>#骨髓坏死#</a> <a href='/topic/show?id=3a13116958b0' target=_blank style='color:#2F92EE;'>#NPM1突变型急性髓系白血病#</a>, objectTitle=EHA 专访｜Olina Lind医生：骨髓纤维化与骨髓坏死：影响NPM1突变型急性髓系白血病（AML）生存的新线索, objectType=article, longId=835787, objectId=a9d4835e8759, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240722/1721625059819_92910.png, objectUrl=/article/show_article.do?id=a9d4835e8759, replyNumber=0, likeNumber=0, createdTime=2024-07-22, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a9d4835e8759, moduleTitle=EHA 专访｜Olina Lind医生：骨髓纤维化与骨髓坏死：影响NPM1突变型急性髓系白血病（AML）生存的新线索, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a9d4835e8759)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215993, encodeId=67ab22159933d, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=3033898847f' target=_blank style='color:#2F92EE;'>#血细胞减少#</a>, objectTitle=【Leukemia】治疗骨髓纤维化的国际共识工作组建议，聚焦于血细胞减少, objectType=article, longId=835426, objectId=57e28354269e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240718/1721282427434_92910.jpg, objectUrl=/article/show_article.do?id=57e28354269e, replyNumber=0, likeNumber=93, createdTime=2024-07-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=57e28354269e, moduleTitle=【Leukemia】治疗骨髓纤维化的国际共识工作组建议，聚焦于血细胞减少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=57e28354269e)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213282, encodeId=0ee42213282e9, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=850849e666e' target=_blank style='color:#2F92EE;'>#异基因造血干细胞移植#</a>, objectTitle=【Blood Adv】骨髓纤维化患者异基因移植的供者类型影响结局：CIBMTR研究结果, objectType=article, longId=832998, objectId=a6a083299806, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240704/1720098094879_1608702.png, objectUrl=/article/show_article.do?id=a6a083299806, replyNumber=0, likeNumber=161, createdTime=2024-07-04, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a6a083299806, moduleTitle=【Blood Adv】骨髓纤维化患者异基因移植的供者类型影响结局：CIBMTR研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a6a083299806)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2194264, encodeId=b700219426420, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=b2d849e64c4' target=_blank style='color:#2F92EE;'>#异基因移植#</a>, objectTitle=【AJH】改善骨髓纤维化异基因移植预后的13个问题, objectType=article, longId=817562, objectId=133181e56273, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/close-up-of-doctors-with-clipboard-at-hospital-PXE5DKE.jpg, objectUrl=/article/show_article.do?id=133181e56273, replyNumber=0, likeNumber=93, createdTime=2024-03-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=133181e56273, moduleTitle=【AJH】改善骨髓纤维化异基因移植预后的13个问题, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=133181e56273)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2189027, encodeId=f915218902ebb, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a> <a href='/topic/show?id=4ba395994d' target=_blank style='color:#2F92EE;'>#II期临床#</a> <a href='/topic/show?id=b73c1114e24c' target=_blank style='color:#2F92EE;'>#jakinib#</a>, objectTitle=Am. J. Hematol | ZGJAK002临床试验长期随访结果分析：Jakinib100mg BID和200mg QD两种剂量在初治骨髓纤维化（MF）患者中的疗效和安全性, objectType=article, longId=814488, objectId=ece88144885c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240223/1708698378759_6145188.jpg, objectUrl=/article/show_article.do?id=ece88144885c, replyNumber=0, likeNumber=122, createdTime=2024-02-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=ece88144885c, moduleTitle=Am. J. Hematol | ZGJAK002临床试验长期随访结果分析：Jakinib100mg BID和200mg QD两种剂量在初治骨髓纤维化（MF）患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ece88144885c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2093536, encodeId=cbd72093536e9, content=<a href='/topic/show?id=8b8d13658cf' target=_blank style='color:#2F92EE;'>#Pacritinib#</a>通过抑制<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a>中的ACVR1改善输血依赖性<a href='/topic/show?id=9fdd92442ed' target=_blank style='color:#2F92EE;'>#贫血#</a>, objectTitle=SOHO 2022：Pacritinib通过抑制骨髓纤维化中的ACVR1改善输血依赖性贫血, objectType=article, longId=743133, objectId=1b64e43133fe, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/160519_CSC.jpg, objectUrl=/article/show_article.do?id=1b64e43133fe, replyNumber=0, likeNumber=133, createdTime=2022-10-13, rootId=0, userName=showtest, userId=8f0715, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1b64e43133fe, moduleTitle=SOHO 2022：Pacritinib通过抑制骨髓纤维化中的ACVR1改善输血依赖性贫血, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1b64e43133fe)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1214322, encodeId=8298121432266, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a>, objectTitle=2021共识建议：芦可替尼在骨髓纤维化治疗中的应用（更新版）, objectType=guider, longId=15693, objectId=47c6a1c002305aa9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=47c6a1c002305aa9, replyNumber=0, likeNumber=1, createdTime=2022-04-25, rootId=0, userName=病毒猎手, userId=a33789389, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47c6a1c002305aa9, moduleTitle=2021共识建议：芦可替尼在骨髓纤维化治疗中的应用（更新版）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=47c6a1c002305aa9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1204278, encodeId=ff3412042e8b9, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a>, objectTitle=Leukemia：骨髓纤维化患者使用半相合供体和移植后环磷酰胺进行同种异体血液或骨髓移植, objectType=article, longId=221787, objectId=a99e221e875f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/doctor-is-working-at-the-hospital-PTE4SCK.jpg, objectUrl=/article/show_article.do?id=a99e221e875f, replyNumber=0, likeNumber=123, createdTime=2022-03-20, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a99e221e875f, moduleTitle=Leukemia：骨髓纤维化患者使用半相合供体和移植后环磷酰胺进行同种异体血液或骨髓移植, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a99e221e875f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1204277, encodeId=bd9612042e73f, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a>, objectTitle=FDA批准骨髓纤维化新药pacritinib, objectType=article, longId=301202, objectId=0b54301202e6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20220316/1682875ac99544f9b7a413ab2142b5a2.jpg, objectUrl=/article/show_article.do?id=0b54301202e6, replyNumber=0, likeNumber=186, createdTime=2022-03-20, rootId=0, userName=医者仁者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0b54301202e6, moduleTitle=FDA批准骨髓纤维化新药pacritinib, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0b54301202e6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=974850, encodeId=906b9e4850f1, content=<a href='/topic/show?id=8b45102002cf' target=_blank style='color:#2F92EE;'>#骨髓纤维化#</a>，端粒酶抑制剂会不会抗<a href='/topic/show?id=4c239032154' target=_blank style='color:#2F92EE;'>#衰老#</a>？？, objectTitle=J Clin Oncol：端粒酶抑制剂Imetelstat可有效治疗骨髓纤维化！, objectType=article, longId=212908, objectId=0f3421290809, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/517.jpg, objectUrl=/article/show_article.do?id=0f3421290809, replyNumber=0, likeNumber=249, createdTime=2021-06-19, rootId=0, userName=小小医者, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0f3421290809, moduleTitle=J Clin Oncol：端粒酶抑制剂Imetelstat可有效治疗骨髓纤维化！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f3421290809)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

骨髓纤维化

2020-05-29

梅斯管理员

#骨髓纤维化#

原发性骨髓纤维化前期（prePMF）和PMF纤维化期、WHO骨髓纤维化分级

2025-01-09发表于上海

梅斯管理员

#骨髓纤维化# #AML#

【JHO】MD安德森癌症中心大样本研究，AML伴骨髓纤维化的特征和预后

2024-11-26发表于陕西省

梅斯管理员

#骨髓纤维化# #半凝集素-1轴#

Science子刊：复旦大学王冠琳等绘制了骨髓纤维化骨髓中骨髓细胞类型之间的串扰图谱！

2024-10-13发表于上海

梅斯管理员

#骨髓纤维化# #急性髓系白血病#

【BMT】姜尔烈/翟卫华教授团队发现骨髓纤维化影响AML异基因移植结局

2024-09-01发表于上海

梅斯管理员

#骨髓纤维化# #异基因移植#

【TCT】≥70岁骨髓纤维化患者异基因移植是可行的

2024-08-10发表于上海

梅斯管理员

#骨髓纤维化# #EHA 2024# #骨髓坏死# #NPM1突变型急性髓系白血病#

EHA 专访｜Olina Lind医生：骨髓纤维化与骨髓坏死：影响NPM1突变型急性髓系白血病（AML）生存的新线索

2024-07-22发表于上海

梅斯管理员

#骨髓纤维化# #血细胞减少#

【Leukemia】治疗骨髓纤维化的国际共识工作组建议，聚焦于血细胞减少

2024-07-21发表于上海

梅斯管理员

#骨髓纤维化# #异基因造血干细胞移植#

【Blood Adv】骨髓纤维化患者异基因移植的供者类型影响结局：CIBMTR研究结果

2024-07-04发表于上海

梅斯管理员

#骨髓纤维化# #异基因移植#

【AJH】改善骨髓纤维化异基因移植预后的13个问题

2024-03-20发表于上海

梅斯管理员

#骨髓纤维化# #II期临床# #jakinib#

Am. J. Hematol | ZGJAK002临床试验长期随访结果分析：Jakinib100mg BID和200mg QD两种剂量在初治骨髓纤维化（MF）患者中的疗效和安全性

2024-02-24发表于上海

showtest

#Pacritinib#通过抑制#骨髓纤维化#中的ACVR1改善输血依赖性#贫血#

SOHO 2022：Pacritinib通过抑制骨髓纤维化中的ACVR1改善输血依赖性贫血

2022-10-13

病毒猎手

#骨髓纤维化#

2021共识建议：芦可替尼在骨髓纤维化治疗中的应用（更新版）

2022-04-25

医者仁者

#骨髓纤维化#

Leukemia：骨髓纤维化患者使用半相合供体和移植后环磷酰胺进行同种异体血液或骨髓移植

2022-03-20

医者仁者

#骨髓纤维化#

FDA批准骨髓纤维化新药pacritinib

2022-03-20

小小医者

#骨髓纤维化#，端粒酶抑制剂会不会抗#衰老#？？

J Clin Oncol：端粒酶抑制剂Imetelstat可有效治疗骨髓纤维化！

2021-06-19

科室
- - 订阅+
  - 更多科室
工具
服务